NDUFB8P2

Across TCGA pan-cancer cohorts, NDUFB8P2 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated NDUFB8P2 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher NDUFB8P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NDUFB8P2 expression acts as an unfavorable survival marker, although some lineages such as PAAD and SARC show a favorable association.

UVM, PAAD, and KIRC are the cancer types where NDUFB8P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.768	1.000	.001	77	view →
PAAD	DFS	Median	All	0.444	0.272	<.001	71	view →
KIRC	OS	Median	All	0.538	0.690	.001	46	view →
ACC	DFS	Quartile	IV	0.047	0.526	.006	41	view →
LGG	DFS	Quartile	All	0.730	0.892	<.001	20	view →
SARC	OS	Tertile	All	0.734	0.332	.002	20	view →
THYM	DFS	Median	II,III,IV	1.000	0.838	.009	16	view →
UCS	OS	Tertile	All	0.675	0.413	.025	12	view →
LIHC	OS	Tertile	All	0.709	0.854	.008	10	view →
MESO	OS	Tertile	IV	0.928	0.435	.017	9	view →
LUAD	OS	Quartile	All	0.877	0.761	.002	8	view →
CHOL	DFS	Quartile	All	0.806	0.277	.017	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

NDUFB8P2–UVM (OS)

Open the UVM breakdown →